Sirius Medical, a medical device innovator developing the next generation of tumor localization technology, is pleased to announce today that RMS Medical Devices will be commercial partner in Belgium and Luxemburg for Sirius Pintuition. RMS Medical Devices has a strong portfolio in the breast oncology field. Sirius Pintuition fits perfectly within their breast health solution portfolio. Several surgeons and radiologists in Belgium are already interested in our Pintuition system.
“We are proud to collaborate with such an enthusiastic and highly knowledgeable team as RMS Medical Devices”, says Bram Schermers, CEO and co-founder of Sirius Medical, “This partnership allows us to introduce our Sirius Pintuition system to our country neighbors and allows for wider access to our technology for patients and clinicians.”
“We strongly believe that Sirius Medical’s Pintuition technology will bring added value to both users and patients by optimizing workflow, patient comfort and treatment results” says Olivier Wouters, Director Business & Product Development at RMS Medical Devices, “this new and improved tumor localization solution perfectly fits in our Breast Health Solutions portfolio, and we are looking forward to this strategic partnership combining our companies’ strengths and knowledge.”
About RMS Medical Devices
RMS Medical Devices is an independent company headquartered on a central location near Brussels and a geographic focus on the Benelux healthcare industry. With almost 35 years of experience, RMS specializes in the development and distribution of medical solutions taking one of the leading positions within breast health in Benelux. RMS is not only a distribution partner but also focusses on the (co-) development of innovative medical solutions. Our organization is closely monitoring the latest global developments and our team is working with physicians, surgeons and manufacturers on a daily base to optimize diagnostic & treatment options for our patients.
About Sirius Medical
With its roots in the Netherlands Cancer Institute, Sirius Medical was born to make things better. The Sirius Pintuition system was developed by and for surgeons addressing a clear clinical need with a solution that simply makes sense. The Sirius Pintuition system is CE marked and received FDA clearance and is currently commercially available in Western Europe. Our mission is to improve care for cancer patients by delivering unsurpassed, yet affordable solutions that enable precise and efficient surgical removal of tumors.
For more information please contact:
Benjamin Tchang, Marketing manager